SANTONIKA
LIVE

Serial Number

79186358

Owner

Mapix S.à.r.l

Filing Date

Aug 28, 2015

Add to watchlist:

No watchlists yet
View on USPTO

SANTONIKA Trademark

Serial Number: 79186358 • Registration: 5298661

SANTONIKA is a trademark filed by Mapix S.à.r.l on August 28, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Mapix S.à.r.l (6 trademarks)

32-36, Boulevard d'Avranches

Entity Type: 99

Trademark Details

Filing Date

August 28, 2015

Registration Date

October 3, 2017

Published for Opposition

July 18, 2017

Cancellation Date

August 28, 2025

Goods & Services

Import-export agency services; cost price analysis; rental of advertising space; demonstration of goods; conducting marketing studies; consumer advice shop, namely, providing commercial information and advice for consumers; business investigations; marketing research; organization of exhibitions for commercial or advertising purposes; organization of fashion shows for promotional purposes; organization of trade fairs for commercial or advertising purposes; shop window dressing; presentation of goods on communication media, for retail purposes, namely, providing television home shopping services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; sales promotion for others; production of advertising films; publicity material rental; rental of billboards and advertising boards; bill-posting; distribution of samples for publicity purposes; dissemination of advertising matter; direct mail advertising; writing of publicity texts; on-line advertising on a computer network; advertising by mail order, namely, direct mail advertising services; telemarketing services; business management for freelance service providers; commercial administration of the licensing of the goods and services of others; administrative processing of purchase orders; modelling for advertising or sales promotion; price comparison services; pay per click advertising; procurement services for others, namely, purchasing pharmaceutical, veterinary and sanitary preparations and medical supplies for other businesses; business efficiency expert services

Scientific and technological services and research and design relating thereto, namely, scientific research for others, technical research in the field of pharmaceutical studies, pharmaceutical research and development, pharmaceutical drug development services; industrial analysis and research services, namely, industrial research in the field of pharmaceutical drug development; design and development of computer hardware and software; water analysis; chemical analysis; industrial design; graphic arts design; engineering; clinical trials, namely, conducting clinical trials for others; material testing; bacteriological research; biological research; chemical research; research and development of new products for others; scientific research; technical research in the field of pharmaceutical studies; measuring, namely, calibration services; quality control, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of pharmaceutical medications; provision of scientific information, advice and consultancy in relation to carbon offsetting; chemistry services, namely, research in the field of chemistry, laboratory analysis in the field of chemistry; packaging design; scientific laboratory services; styling, namely, industrial design services; physics research; surveying

Medical services; veterinary services; hygienic services for human beings or animals; agriculture services, namely, providing recommendations for plant and soil nutrition supplements; hospitals; health centers, namely, hospital services for persons with physical and/or cognitive disabilities or impairments; medical advice for individuals with disabilities; pharmacy advice, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; veterinary assistance;, namely, emergency veterinary treatment services; rehabilitation for substance abuse patients; health care; health counseling; medical clinic services; speech therapy services; services of a psychologist; telemedicine services; therapy services, namely, physical therapy services; pharmacists' services to make up prescriptions; nursing, medical; physical therapy; plastic surgery

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment of psychoorganic syndrome, neuropsychiatric and psychiatric diseases, nervous system disorders, Alzheimer disease, Parkinson disease, vertigo of different origin, cardiovascular diseases, stroke, cerebrovascular stroke, vegetative-vascular dystonia, neurodegenerative diseases, neuroinfections, somatoform autonomic dysfunction, atherosclerosis, attention deficit disorder, diseases followed by abnormal changes in bioelectrical characteristics of the brain, congestive heart failure, hyperpiesis, neuroticism, psychosomatic disease, stress disorders, asthenic syndrome, neurotoxicosis and obesity; Pharmaceutical and veterinary preparations for use in the treatment of diabetes, type II diabetes, for use in the prevention of complication from diabetes, insulin resistance, parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, fungal infections, viral infections, parainfluenza, adenovirus, respiratory syncytial virus, coronavirus, labially herpes, genital herpes, chicken pox, herpes zoster, infectious mononucleosis, intestinal infections of viral etiology, including calicivirus, adenovirus, coronavirus, rotavirus, enteroviruses, enteroviral and meningococcal meningitis, hemorrhagic fever with renal syndrome, tick-borne encephalitis, bacterial infections, pseudotuberculosis, whooping cough, yersiniosis, pneumonia; Pharmaceutical and veterinary preparations for use in the prevention of bacterial complications of viral infections, prevention of super bacterial infection; pharmaceutical preparations, namely, antihistamines; pharmaceutical preparations for the treatment of AIDS / HIV infection; pharmaceutical preparations, namely, psychotropics; pharmaceutical preparations for the treatment of erectile dysfunction, benign prostatic hyperplasia, prostatitis, dysuric disorders, autonomic disturbances of menopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome, functional gastrointestinal disorders; pharmaceutical preparations, namely, anticonvulsants; pharmaceutical preparations, namely, antianxiety preparations; pharmaceutical preparations, namely, cough treatment preparations; pharmaceutical preparations, namely, preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritis, osteoarthrosis, arthropathy, nonspecific ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratory, pulmonary and circulatory diseases; pharmaceutical and veterinary preparations, namely, antioxidants; pharmaceutical nootropic preparations for use in the improvement of cognitive functions, for use in the treatment of memory diseases and disorders; pharmaceutical vasoprotective preparations for use in the treatment of blood disorders, hemorrhoids, varicose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose in the blood and elevated levels of glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; food for babies; dietary supplements for humans and animals; capsules sold empty for medicines; cachets for pharmaceutical purposes, namely, flat capsules sold empty for enclosing unpleasant-tasting pharmaceuticals; appetite suppressant pills

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Mar 19, 2026 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 8, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 18, 2025 INTS
INVALIDATION PROCESSED
Feb 18, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 20, 2024 INTR
CANCELLED SECTION 71
Apr 19, 2024 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 4, 2018 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 16, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 18, 2018 FICS
FINAL DISPOSITION PROCESSED
Jan 18, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 3, 2017 R.PR
PUBLISHED FOR OPPOSITION
Jul 18, 2017 PUBO
NOTICE OF PUBLICATION
Jun 28, 2017 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2017 CNSA
EXAMINERS AMENDMENT MAILED
May 12, 2017 CNEA
EXAMINER'S AMENDMENT ENTERED
May 11, 2017 XAEC
EXAMINERS AMENDMENT -WRITTEN
May 11, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2017 TROA
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
Oct 11, 2016 NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Oct 9, 2016 NAUD
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2016 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2016 TROA
REFUSAL PROCESSED BY IB
May 27, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 6, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 6, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 6, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 5, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
May 3, 2016 MAFR
ASSIGNED TO EXAMINER
Apr 29, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 28, 2016 REPR